Virag Vas

Senior Research Associate/PostDoc, HUN-REN, Research Centre for Natural Sciences, Budapest, Hungary

KACI HANA

PhD STUDENT , RCNS, Institute of Molecular Life Sciences & Eötvös Loránd University (ELTE)

Subham Preetam

Early Stage Researcher (R1), DGIST

Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals. With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. His research aims to improve the life expectancy of sea animals and humans. Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer patients in South Korea and Sweden. Additionally, he collaborates with researchers from India, Taiwan, Israel, US, Denmark, Singapore, Spain, Portugal, and the United Kingdom on various collaborative projects.
Zoltan Lipinszki

Group leader, PI, Biological Research Centre, Institute of Biochemistry

Hasan Mamar

PhD student, Biological Research Center/ University of Szeged

Laszlo Nyitray

Full Professor, Eötvös Loránd University, Budapest

Giulia Faravelli

Postdoc, University of Pavia

Alexander Röntgen

PhD Student, University of Cambridge

Abdel fattah, Gamal Moustafa

biochemistry researcher, faculty of science, Alxanderia university

iam graduated from faculty of science, chemistry and biochemistry dep. i have a biomedical analysis diploma. my master degree focused in treatment diabetes with the combination therapy using natural products and a pharmaceutical. i hope to find a PHD position in biochemistry. mainly my interest in biochemistry. title of thesis( treatment of HFD induced diabetes with combination of metformin and natural products)
Isabel Varela Nieto

Research Professor, CSIC

Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.